13F reference period
Q2 2026
Security Snapshot
Endovia Health Sciences, Inc. - Common Stock, par value $0.001 per share (SBEV) Institutional Ownership
CUSIP: 84862C302
13F Institutional Holders and Ownership History from Q1 2025 to Q3 2026
Institutions Reporting
17
Shares (Excl. Options)
1.11M
Full value: 1,110,117 · shares · 30 Jun 2026Price
$0.16
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- SBEV
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,110,117
- Total 13F value
- $171,986
- Portfolio coverage rank
- 0%
- Share change
- +365,753
- Value change
- +$44,692
- Number of holders
- 17
- Shares outstanding
- 2,586,207
- SEC-reported price per share
- $0.12
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- SBEV - Endovia Health Sciences, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 84862C302.
- 17 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 17 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$243.93K
Full value: $243,928 · USD · 31 Mar 2026.$171.99K
Full value: $171,986 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 17 institutions filings for Q2 2026.
Security key
84862C302
13F reference period
Q2 2026
13F holders
17
13D/G owners
8
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 84862C302:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
SBEV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Devereux William T | 29% | $2,301,450 | 1,005,000 | Devereux William T | 31 Jul 2025 | |||
| Yorke Justin W | 29% | $2,079,272 | 907,979 | Yorke Justin W | 31 Jul 2025 | |||
| Caple Frederick William | 24% | $1,757,575 | 767,500 | Caple Frederick William | 31 Jul 2025 | |||
| Meissner William R. | 24% | $1,723,225 | 752,500 | Meissner William R. | 31 Jul 2025 | |||
| Fore Thomas Butler | 24% | $1,717,500 | 750,000 | Fore Thomas Butler | 31 Jul 2025 | |||
| Tong Magdalene | 7.7% | $458,000 | 200,000 | Tong Magdalene | 31 Jul 2025 | |||
| Nistico Robert | 7.1% | $413,276 | 180,470 | Nistico Robert | 31 Jul 2025 | |||
| Aragon Aida | 5.8% | $343,500 | 150,000 | Aida Aragon | 31 Jul 2025 |
As of 30 Jun 2026,
17
institutional investors reported holding
shares of
Endovia Health Sciences, Inc. - Common Stock, par value $0.001 per share (SBEV).
This represents
43%
of the company’s total
outstanding shares.
1.11M
Full value: 1,110,117 · shares · 30 Jun 20262.59M
Full value: 2,586,207 · shares · Stored outstanding share count13F concentration
Top 20 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
43%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 13% | 348,418 | 0% | $54,004 | |
| Phraction Management LLC | 4.8% | 123,648 | +77% | 0% | $19,165 |
| Summit Trail Advisors, LLC | 3.9% | 100,000 | 0% | 0% | $15,500 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 68,591 | +19% | 0% | $10,631 |
| TRUIST FINANCIAL CORP | 2.6% | 67,819 | +107% | 0% | $10,512 |
| Lifetime Wealth Management P.C. | 2.6% | 66,050 | 0% | 0.01% | $10,238 |
| COMPASS FINANCIAL MANAGEMENT LLC | 2.5% | 64,500 | 0% | 0% | $9,998 |
| Virtu Financial LLC | 2.3% | 59,897 | -40% | 0% | $9,000 |
| Point72 Asset Management, L.P. | 2.2% | 56,950 | 0% | $8,827 | |
| HRT FINANCIAL LP | 2.2% | 56,687 | -58% | 0% | $8,000 |
| CHOREO, LLC | 1.3% | 34,027 | 0% | 0% | $5,274 |
| StoneX Group Inc. | 1.1% | 28,151 | 0% | $5,352 | |
| GOLDMAN SACHS GROUP INC | 0.79% | 20,405 | 0% | $3,163 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.42% | 10,934 | 0% | 0% | $1,695 |
| Tower Research Capital LLC (TRC) | 0.16% | 4,019 | 0% | 0% | $623 |
| Delos Wealth Advisors, LLC | 0% | 16 | 0% | 0% | $3 |
| SBI Securities Co., Ltd. | 0% | 5 | -93% | 0% | $1 |
| UBS Group AG | 0% | 0 | -100% | $0 | |
| Vanguard Global Advisers, LLC | 0% | 0 | -100% | $0 | |
| CITADEL ADVISORS LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Headline period
Q2 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 0 | $0 | -$55,188 | $0.12 | 0 |
| 2026 Q2 | 1,110,117 | $171,986 | +$44,692 | $0.16 | 17 |
| 2026 Q1 | 679,864 | $243,928 | +$158,512 | $0.36 | 15 |
| 2025 Q4 | 217,473 | $150,721 | -$20,621 | $0.69 | 14 |
| 2025 Q3 | 108,383 | $255,673 | +$91,779 | $2.36 | 17 |
| 2025 Q2 | 69,382 | $260,876 | +$12,582 | $3.76 | 12 |
| 2025 Q1 | 66,708 | $93,391 | +$93,391 | $1.40 | 11 |